About 200 reports

  • WHAT IS A BIOSIMILAR?
  • What Is a Biosimilar?

Biosimilars in Oncology Report Code: GDHCHT## Published: August 2018 Healthcare TABLE OF CONTENTS (##/ ##) ##.

  • Biosimilar
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

Global Biosimilars and Follow-On Biologics Market 2019-2029 ## Report Overview ##. ## Biosimilar Overview ##. ## Biosimilars Market Segmentation ##. ## Why You Should Read this Report ##. ## How this Report Delivers ##. ## Main Questions Answered by this Report ##. ## Who i

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Shares
  • Market Size
  • RECENT DEVELOPMENTS IN BIOSIMILAR IN JAPAN
  • GLOBAL BIOSIMILARS MARKET - OVERVIEW

Note: ##.

  • Biosimilar
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

REST OF WORLD PART D: ANNEXURE ##.

  • Biosimilar
  • Europe
  • North America
  • World
  • Market Shares

Global Biosimilars Partnering Terms and Agreements 2014 to 2019 Chapter ## – Introduction Chapter ## – Trends in Biosimilars dealmaking ##. ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Demand
  • 6. The Biosimilar Pipeline
  • 3. The Biosimilar Opportunity

THESE TABLES ARE SUMMARIZED IN Figure ##: Waves of Biosimilar Opportunity by Patent Expiry of Innovator Biologics.

  • Biosimilar
  • AbbVie Inc.
  • Alexion Pharmaceuticals, Inc.
  • Amgen Inc.
  • AstraZeneca PLC

ZYDUS CADILA Chapter ## Appendix: Abbreviations List of Tables Summary Table : Global Market for Biosimilars, by Type, Through 2022 Table ## : List of Biosimilars Produced in E.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Biosimilars
  • Concerns with biosimilars

Familiarity with biosimilar IFX ##% of physicians reported having prescribed Remsima to at least one IBD patient & ##% of physicians have prescribed Inflectra to one of their IBD patients Physicians were generally more familiar with Remsima & Inflectra

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Remicade group

GLOBAL BIOSIMILAR MONOCLONAL ANTIBODIES FORECAST 2018-2028 ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Shares
  • Market Size
  • Sandoz Major Biosimilar Pipeline
  • Biosimilars Vs Generics

Global Biosimilar Market: Size, Trends & Forecasts (2016-2020) November 2016 ##.

  • Biosimilar
  • Amgen Inc.
  • Celltrion, Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • Approval process for biosimilars in US
  • Biosimilars market opportunities

Factors such as the patients and physician’s willingness to switch to biosimilars and the price advantage of biosimilars over biologics, will provide considerable growth opportunities to biosimilars manufactures.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Market Size
  • Biosimilars in South Korea
  • Biosimilars in Brazil

UBS; ##-##.

  • Biosimilar
  • Amgen Inc.
  • Biocon Limited
  • Celltrion, Inc.
  • Pfizer Inc.

##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size
  • BIOGENERICS
  • BIOSIMILARS

TABLE OF CONTENTS (##/ ##) ##.

  • Biosimilar
  • Medical Biotechnology
  • Market Size
  • Supply
  • Remicade group

Biosimilars Market By Product, By Technology, By Indication, By Manufacturing Type, By Route of Administration, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2014-2024 Chapter ##.

  • Biosimilar
  • Europe
  • North America
  • World
  • Market Size

Biosimilars Real World Evidence: Proving the point ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • World

Biosimilars Market Snapshot Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025 Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025 Table ## Global Oncology Biosimilars Marke

  • Biosimilar
  • Medical Biotechnology
  • APAC
  • World
  • Market Size

##.

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • World
  • Market Size

Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023 ## Preface ## Scope and Methodology ##. ## Objectives of the Study ##. ## Stakeholders ##. ## Data Sources ##. ##. ## Primary Sources ##. ##. ## Secondary Sources ##. ## Market Estimation ##. ##. ## Bottom-Up App

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size

Commercialisaton of Biosimilars: Multifunctional teamwork for success ##.

  • Biosimilar
  • Medical Biotechnology
  • World

Biosimilars: EU Payer Perspectives ##.

  • Biosimilar
  • Medical Biotechnology
  • Europe

AbbVie Hit Harder By EU Humira Biosimilars Than Projected With the launch of Europe’s first adalimumab (Humira) biosimilars in October of 2018, leaders at AbbieVie faced tough questions from stakeholders and analysts during their Q## earnings call.

  • Biosimilar
  • Europe
  • European Union
  • United States
  • World

Though the European launch of a few Humira biosimilars is not expected to do big damage to the arthritis and Crohn’s disease giant, biosimilars are now poised to alter price, access, and treatment pathways.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Europe
  • World

APAC Biosimilar Market, Forecast 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Market Size

Physician reluctance to use biosimilars interchangeably with the original product may prove to be an issue, albeit one that can be overcome with education efforts.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Forecast
  • 8.3.1 BIOSIMILARS
  • 7.2.2 PIPELINE BIOSIMILARS

ONE MAJOR DRIVER OF THIS DECLINE IS THE ENTRY OF BIOSIMILARS INTO THE MARKET.

  • Biosimilar
  • Demand
  • Forecast
  • Pfizer Inc.
  • Sanofi S.A.

US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • United States
  • Market Size

Global Biosimilar Market Outlook 2022 ##.

  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size

You can request one free hour of our analyst’s time when you purchase this market report.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size